- Home
- DHC vs ARCT Comparison
DHC vs ARCT Comparison
Compare DHC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHC
- ARCT
- Stock Information
- Founded
- DHC 1998
- ARCT 2013
- Country
- DHC United States
- ARCT United States
- Employees
- DHC N/A
- ARCT N/A
- Industry
- DHC Real Estate Investment Trusts
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- DHC Real Estate
- ARCT Health Care
- Exchange
- DHC Nasdaq
- ARCT Nasdaq
- Market Cap
- DHC 629.7M
- ARCT 487.0M
- IPO Year
- DHC N/A
- ARCT N/A
- Fundamental
- Price
- DHC $2.63
- ARCT $15.88
- Analyst Decision
- DHC Hold
- ARCT Strong Buy
- Analyst Count
- DHC 3
- ARCT 8
- Target Price
- DHC $4.50
- ARCT $61.00
- AVG Volume (30 Days)
- DHC 989.6K
- ARCT 405.9K
- Earning Date
- DHC 02-25-2025
- ARCT 03-06-2025
- Dividend Yield
- DHC 1.54%
- ARCT N/A
- EPS Growth
- DHC N/A
- ARCT N/A
- EPS
- DHC N/A
- ARCT N/A
- Revenue
- DHC $1,477,343,000.00
- ARCT $160,399,000.00
- Revenue This Year
- DHC N/A
- ARCT $7.33
- Revenue Next Year
- DHC $4.46
- ARCT $4.71
- P/E Ratio
- DHC N/A
- ARCT N/A
- Revenue Growth
- DHC 6.62
- ARCT N/A
- 52 Week Low
- DHC $2.01
- ARCT $14.30
- 52 Week High
- DHC $4.24
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- DHC 67.74
- ARCT 41.74
- Support Level
- DHC $2.39
- ARCT $16.03
- Resistance Level
- DHC $2.50
- ARCT $17.95
- Average True Range (ATR)
- DHC 0.13
- ARCT 1.29
- MACD
- DHC 0.07
- ARCT -0.07
- Stochastic Oscillator
- DHC 93.85
- ARCT 10.29
About DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.